<SEC-DOCUMENT>0001040130-25-000049.txt : 20250812
<SEC-HEADER>0001040130-25-000049.hdr.sgml : 20250812
<ACCEPTANCE-DATETIME>20250812162055
ACCESSION NUMBER:		0001040130-25-000049
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250811
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250812
DATE AS OF CHANGE:		20250812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42429
		FILM NUMBER:		251207040

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pets-20250811.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:203c903d-b79e-4d7b-8b98-578e1b9f15fc,g:2c359b4f-5c7f-4790-b33d-259153bfdc3e,d:754ae29a438049c7b72e3a914bacc337-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pets-20250811</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0001040130</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pets-20250811.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-11</xbrli:startDate><xbrli:endDate>2025-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-11</xbrli:startDate><xbrli:endDate>2025-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-11</xbrli:startDate><xbrli:endDate>2025-08-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i754ae29a438049c7b72e3a914bacc337_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 11, 2025</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">PetMed Express, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Florida</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-28827</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">65-0680967</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">420 South Congress Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Delray Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">33445</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">561</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">526-4444</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-17">Common Stock, par value $.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-18">PETS</ix:nonNumeric></span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" id="f-19">NASDAQ</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-20">Preferred Stock Purchase Rights</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="dei:NoTradingSymbolFlag" format="ixt:fixed-true" id="f-21">N/A</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" id="f-22">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the </span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:125%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><div id="i754ae29a438049c7b72e3a914bacc337_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Resignation of Sandra Campos</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">              On August 11, 2025, following a meeting of the Board of Directors (the &#8220;Board&#8221;) of PetMed Express, Inc. (the &#8220;Company&#8221;), the Company and Sandra Campos entered into a Separation Agreement pursuant to which Ms. Campos resigned as the Chief Executive Officer (Principal Executive Officer) and President of the Company, effective immediately (the &#8220;Campos Separation Agreement&#8221;). </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of the Campos Separation Agreement, in exchange for the execution by Ms. Campos of a general release and waiver of claims against the Company and an agreement to provide the Company with consulting services for a period of 3 months on an as-needed basis, the Company will pay Ms. Campos severance compensation in the form of the continuation of her annual base salary of $550,000 for a period of 13 months and reimbursement of COBRA premiums for 18 months. The Campos Separation Agreement also provides that the Company will, to the extent not already vested, accelerate the vesting of a pro-rata portion of the restricted stock units previously awarded to her (calculated based on the number of days during the full vesting period of each such award during which Ms. Campos was employed by the Company). All other restricted stock units and performance stock units will be forfeited. The Campos Separation Agreement provides that Ms. Campos&#8217; Executive Employment Agreement, dated April 29, 2024, with the Company is terminated effective immediately, subject to continuation of certain covenants (including restrictive covenants) by Ms. Campos. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing does not purport to be a complete description of the Campos Separation Agreement and is qualified in its entirety by reference to the full text of such agreement, which is attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As a part of Ms. Campos&#8217; resignation as an officer of the Company, Ms. Campos also resigned as a director of the Company on and effective as of August 11, 2025.  Her resignation as a director is not due to a disagreement with the Company on any matter relating to the Company&#8217;s operations, policies, or practices.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In connection with Ms. Campos&#8217; resignation as a director of the Company, effective as of August 11, 2025, the Board reduced the number of directors on the Board from six directors to five directors pursuant to the authority of the Board under the Company&#8217;s Third Amended and Restated Bylaws to establish the number of directors on the Board from time to time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Resignation of Robyn D&#8217;Elia</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On August 11, 2025, following a meeting of the Board, the Company and Robyn D&#8217;Elia entered into a Separation Agreement pursuant to which Ms. D&#8217;Elia resigned as the Chief Financial Officer and Treasurer (Principal Financial Officer) of the Company, effective immediately (the &#8220;D&#8217;Elia Separation Agreement&#8221;). </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Under the terms of the D&#8217;Elia Separation Agreement, in exchange for the execution by Ms. D&#8217;Elia of a general release and waiver of claims against the Company and an agreement to provide the Company with consulting services for a period of 3 months on an as-needed basis, the Company will pay Ms. D&#8217;Elia severance compensation in the form of the continuation of her annual base salary of $425,000 for a period of 13 months and reimbursement of COBRA premiums for 18 months. The D&#8217;Elia Separation Agreement also provides that the Company will, to the extent not already vested, accelerate the vesting of a pro-rata portion of the restricted stock units previously awarded to her (calculated based on the number of days during the full vesting period of the restricted stock unit award during which Ms. D&#8217;Elia was employed by the Company).  All other restricted stock units will be forfeited. The D&#8217;Elia Separation Agreement provides that Ms. D&#8217;Elia&#8217;s Executive Employment Agreement, dated September 16, 2024, with the Company is terminated effective immediately, subject to continuation of certain covenants (including restrictive covenants) by Ms. D&#8217;Elia.  </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing does not purport to be a complete description of the D&#8217;Elia Separation Agreement and is qualified in its entirety by reference to the full text of such agreement, which is attached as Exhibit 10.2 to this Current Report on Form 8-K and incorporated herein by reference.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Appointment of Interim Chief Executive Officer and President</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On and effective as of August 11, 2025, the Board appointed Leslie C.G. Campbell, the Chair of the Board, Chair of the Audit Committee, and a member of the Compensation and Human Capital Committee, as the Interim Chief Executive Officer and President of the Company.  In her capacity as Interim Chief Executive Officer and President, Ms. Campbell will serve as, and perform the functions of, the principal executive officer of the Company on an interim basis. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In connection with her appointment as the Interim Chief Executive Officer and President of the Company, Ms. Campbell has resigned effective August 11, 2025 as Chair of the Audit Committee and as a member of the Audit Committee and the Compensation and Human Capital Committee. On and effective as of the same date, the Board appointed Peter Batushansky (an existing member of the Audit Committee) as Chair of the Audit Committee, and Leah Solivan (an existing member of the Compensation and Human Capital Committee) has been appointed as the Chair of the Compensation and Human Capital Committee to succeed Mr. Batushansky as prior Chair of such committee.  Ms. Campbell will continue to serve as the Chair of the Board, and Justin Mennen has been appointed to serve as Lead Independent Director of the Board.    </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Campbell, age 67, has served as a member of the Board since July 2018 and as Chair of the Board since January 2024. She also served as a member of the Compensation and Human Capital Committee of the Board from July 2018 to August 2025 and as Chair of the Compensation and Human Capital Committee from August 2023 to July 2025. Ms. Campbell served as a member of the Audit and Corporate Governance and Nominating Committees from July 2018 to May 2024, as Chair of the Corporate Governance and Nominating Committee from July 2018 to August 2023, and as Chair of the Audit Committee from July 2025 to August 2025. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Ms. Campbell is an experienced public board director and former international executive with multi-disciplinary expertise and a history of global corporate leadership.  Ms. Campbell previously served as the chief procurement officer for Reed Elsevier, Inc., a FTSE 100 provider of professional information solutions in the science, medical, legal, risk, and business sectors, from 2007 to 2012. From 1998 to 2007, Ms. Campbell held a number of senior positions at Dell, Inc., including as the Vice President of Worldwide Procurement, and previously as the Vice President and General Manager, Global Segment EMEA. Ms. Campbell held a number of positions at Oracle Corporation from1990 to 1998. From 1982 to1990, she held a number of positions at KPMG Peat Marwick LLP, a member firm of KPMG International,  and was licensed as a Certified Public Accountant. Ms. Campbell holds a B.A. in Business Administration from the University of Washington. Ms. Campbell serves on the Board of Directors, and chairs the Audit Committee of privately held PointClickCare, a market leading healthcare software company based in Toronto, Canada.  She also serves on the Board of Directors and Executive Committee of Bideawee, Inc., one of America&#8217;s first no-kill animal welfare organizations. Previously, Ms. Campbell served on the boards of LiveVox Holdings, Inc. NASDAQ:LVOX (Audit Committee Chair); Shapeways Holdings Inc. NASDAQ:SHPW (Chairman of the Board, Compensation and Human Capital Committee Chair); and Coupa Software (NASDAQ:COUP (Nominating and Corporate Governance Committee Chair).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There are no family relationships between Ms. Campbell and any other executive officers or directors of the Company. There is no arrangement or understanding between Ms. Campbell and any other persons pursuant to which she was selected to serve as the Interim Chief Executive Officer and President of the Company. There are no transactions in which the Company is a participant and in which Ms. Campbell has a material interest that is required to be disclosed under Item 404(a) of Regulation S-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Board has not yet determined the compensation that will be paid to Ms. Campbell for her service as Interim Chief Executive Officer and President.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Appointment of Interim Principal Financial Officer </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On and effective as of August 11, 2025, the Board appointed Doug Krulik, the Chief Accounting Officer of the Company, to serve as the Interim Principal Financial Officer of the Company. Mr. Krulik will also serve as Treasurer of the Company and continue to serve as the Chief Accounting Officer and Principal Accounting Officer of the Company.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Mr. Krulik, age 56, has served as the Chief Accounting Officer (Principal Accounting Officer) of the Company since August 2024. Prior to joining the Company, he served as Vice President Finance and Controller at Etherio Holdings, a private events and marketing company, from 2021 to 2024. Prior to Etherio, Mr. Krulik served as Vice President Finance and Controller at Jushi Holdings, Inc., a public company with rapidly growing retail and wholesale businesses, from 2019 to 2021. Mr. Krulik was the Financial Reporting Manager for Technical Accounting at Magic Leap, a private and rapidly growing technology startup company, from 2016 to 2019 and served as Controller of Hollywood Companies, a group of private and public media companies, from 2011 to 2016. Prior to Hollywood Companies, Mr. Krulik served in a variety of accounting and finance leadership roles at American Media and Benihana and was an Audit Manager with Deloitte &amp; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Touche. Mr. Krulik is a Certified Public Accountant and holds a Masters of Business Administration from the University of Miami.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">There are no family relationships between Mr. Krulik and any other executive officers or directors of the Company. There is no arrangement or understanding between Mr. Krulik and any other persons pursuant to which he was selected to serve as the Interim Principal Financial Officer of the Company. There are no transactions in which the Company is a participant and in which Mr. Krulik has a material interest that is required to be disclosed under Item 404(a) of Regulation S-K.</span></div><div><span><br/></span></div><div id="i754ae29a438049c7b72e3a914bacc337_10"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01 Regulation FD Disclosure.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On August 12, 2025, the Company issued a press release announcing the management changes described in Item 5.02 of this Current Report on Form 8-K.  A copy of this press release is furnished with this report as Exhibit 99.1 and incorporated herein by reference.    </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The information in this Item 7.01 and the related information in Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth by specific reference in such filing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i754ae29a438049c7b72e3a914bacc337_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 8.01 Other Events.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in a Current Report on Form 8-K filed by the Company on July 1, 2025, the Company&#8217;s Audit Committee, with the aid of external legal counsel and other external advisors, is investigating certain anonymous whistleblower hotline reports received by the Audit Committee regarding the timing of revenue recognition with respect to certain autoship orders in the fiscal fourth quarter of 2025, some of which resulted in customer complaints; a fiscal fourth quarter 2025 $50 coupon promotion to customers and its potential impact on Company key-performance indicators (KPIs) regarding new customers; and the Company&#8217;s culture and control environment.  The Audit Committee&#8217;s investigation is ongoing, and the Audit Committee is working diligently to complete its investigation as soon as practicable.</span></div><div><span><br/></span></div><div id="i754ae29a438049c7b72e3a914bacc337_13"></div><div style="margin-top:10pt"><span><br/></span></div><div style="-sec-extract:summary;margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:125%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.173%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-camposexecseparationa.htm">Separation Agreement, dated August 11, 2025, between the Company and Sandra Campos. </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-deliaexecseparationag.htm">Separation Agreement, dated August 11, 2025, between the Company and Robyn D&#8217;Elia.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20250812xexx991pressr.htm">Press Release dated A</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20250812xexx991pressr.htm">ugust</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20250812xexx991pressr.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20250812xexx991pressr.htm">12</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pets-20250812xexx991pressr.htm">, 2025</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL)</span></div></td></tr></table></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">*  *  *</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">4</span></div></div></div><div id="i754ae29a438049c7b72e3a914bacc337_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Dated: August 12, 2025</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">PETMED EXPRESS, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:125%">/s/ Robert Lawsky</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Name:</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Robert Lawsky</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">General Counsel</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:125%">5</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>pets-camposexecseparationa.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="icba043f48db54433862d4e9757519ff2_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">SEPARATION AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;THIS SEPARATION AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;Agreement&#8221;) is dated as of August 11, 2025 (the &#8220;Effective Date&#8221;), by and between Sandra Campos, an individual (&#8220;Executive&#8221;), and PETMED EXPRESS, INC., a Florida corporation whose principal place of business is located at 420 South Congress Avenue, Delray Beach, FL 33445 (the &#8220;Company&#8221;). The Company and Executive are sometimes individually referred to in this Agreement as a &#8220;Party&#8221; and collectively as the &#8220;Parties.&#8221;  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">RECITALS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;Executive is currently employed by the Company as the Company&#8217;s Chief Executive Officer and President and is a member of its Board of Directors, and in connection therewith, the Company and Executive are parties to an Executive Employment Agreement with an effective date of April 29, 2024 (the &#8220;Employment Agreement&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;Executive and the Company desire to hereby set forth certain mutual agreements and understandings relating to the separation of Executive from the Company as set forth below in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">NOW THEREFORE, in consideration of the mutual promises set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, do hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">TERMS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Recitals</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  The foregoing Recitals are true and correct and are incorporated into this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Executive agrees that she has voluntarily resigned from her employment with the Company and its subsidiaries effective as of the close of business on August 11, 2025 (the &#8220;Employment Termination Date&#8221;). The Parties agree this Agreement shall constitute notice of said termination as set forth in Sections 4(iv) and 8 of the Employment Agreement. Executive hereby irrevocably waives any right to receive any advance notice of termination as set forth in Section 4(iv) of the Employment Agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Executive agrees that the Employment Agreement is terminated effective as of the Employment Termination Date and that neither Executive nor the Company will have any further rights or obligations under the Employment Agreement, provided that such termination of the Employment Agreement shall not affect (i) Executive&#8217;s obligations under, and the provisions set forth in, Sections 5, 9, 10, 14, 18 of the Employment Agreement, which shall remain in full force and effect after the Employment Termination Date in accordance with the terms and provisions thereof (such obligations of Executive, the &#8220;Continuing Obligations&#8221;), and (ii) Executive&#8217;s indemnification rights (and the Company&#8217;s corresponding indemnification obligations) pursuant to and in accordance with (A) the Indemnification Agreement, between Executive and the Company, (B) the indemnification provisions of Sections 607.0850 through 607.0859 of the Florida Business Corporation Act, and (C) Article 9 of the Company&#8217;s Third Amended and Restated Bylaws (collectively, the &#8220;Indemnification Rights&#8221;).  Executive also agrees that she will at all times after the Effective Date and Employment Termination Date continue to be subject to the PetMed Express, Inc. Executive Compensation Recovery Policy.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding clause (i) of the preceding, the covenant set forth in the first two sentences of Section 5(b) of the Employment Agreement shall not be a Continuing Obligation after the expiration of the Consulting Period (as defined below) and shall terminate effective as of the end of the Consulting Period, provided that all other obligations in Section 5 of the Employment Agreement shall survive the expiration of the Consulting Period and constitute a Continuing Obligation at all times.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive hereby resigns, as of the Employment Termination Date, from the offices of Chief Executive Officer and President, and from all other offices, directorships, manager positions, trusteeships, committee memberships and fiduciary and other capacities held with, or on behalf of, the Company and its direct and indirect subsidiaries, and Executive&#8217;s execution of this Agreement will be deemed the </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">grant</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> by Executive to the officers of the Company of a limited power of attorney to sign in Executive&#8217;s name and on Executive&#8217;s behalf any such documentation as may be required to be executed solely for the limited purposes of effectuating such resignations.  In furtherance of the foregoing, Executive hereby resigns as a director of the Company as of the Employment Termination Date and acknowledges that such termination is not the result of any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies, or practices.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Post-Termination Consulting Services&#59; Cooperation and Assistance</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;In consideration of and as an inducement to the Company entering into this Agreement when not otherwise obligated to do so, Executive agrees that she will, during the three-month period commencing on the Employment Termination Date (the &#8220;Consulting Period&#8221;), provide the Company, on an as-needed and as-requested basis, such consulting services as the Company may from time to time reasonably request relating to matters that were within the purview of Executive&#8217;s role and duties to the Company during her employment (the &#8220;Consulting Services&#8221;), up to a maximum of five (5) hours of Consulting Services during each calendar week during the Consulting Period.  The Consulting Services shall be rendered remotely and may include, without limitation and at the request of the Company, being available by email, through internet connection, and by telephone during normal business hours during ordinary business days, to answer questions and provide information and assistance relating to, and to otherwise cooperate with the Company and its management with respect to, transitional matters and other matters that Executive was involved with during the term of her employment with the Company.  The Consulting Services shall be rendered for no additional compensation other than payment of the compensation described in Section 5 below.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;In addition to the Consulting Services and in consideration of the benefits provided for in Section 5 below, Executive agrees to reasonably cooperate with the Company and any of the Released Parties (as defined below) as to any current or future litigation, internal investigations, information inquiry, or contractual disputes on matters in which she was involved or about which Executive gained knowledge while an employee or director of the Company. This duty of cooperation shall include, but shall not be limited to&#58; (a) meeting with the Company&#8217;s or the Released Parties&#8217; attorneys by telephone or in person at mutually convenient times and places in order to state truthfully Executive&#8217;s knowledge of the matters at issue and recollection of events (including an initial meeting to be held within 24 hours of the time that this Agreement is executed)&#59; and (b) signing, at Company&#8217;s, Released Parties&#8217;, or their attorneys&#8217; request, declarations or affidavits that truthfully state the matters of which Employee has knowledge. General information or background inquiries will be answered by the Executive within two (2) </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">business days. When it seeks future cooperation, the Company will endeavor to avoid disrupting or interfering with the Executive&#8217;s future employment or future business or personal obligations, and the Executive will not unnecessarily or unreasonably claim or assert interference with her future business or personal obligations.  The Company agrees to reimburse Executive for reasonable out-of-pocket expenses (including reasonable attorneys&#8217; fees pursuant to the Indemnification Rights) incurred at the request of the Company with respect to this Section 3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Outstanding Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. The Parties agree and acknowledge that the outstanding equity awards held by Executive shall be treated in the manner set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> hereto, which is incorporated into this Agreement by this reference.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consideration.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">  In consideration of Executive&#8217;s agreements, releases, and covenants set forth in this Agreement, so long as (i) Executive does not revoke this Agreement pursuant Sections 20 or 21 of this Agreement (and no payments hereunder shall be due until the expiration of the Revocation Period, as defined below), and (ii) Executive complies with the terms and provisions of this Agreement, Executive will be entitled to the following compensation&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Payment of an amount equal to the sum of (i) Five Hundred Fifty Thousand dollars ($550,000.00), which is the equivalent of twelve (12) months of Executive&#8217;s current Base Salary (as defined in the Employment Agreement) plus (ii) an additional Forty Five Thousand Eight Hundred Thirty Three dollars ($45,833) in lieu of the notice period contemplated by Section 4(iv) of the Employment Agreement, for an aggregate of Five Hundred Ninety Five Thousand Eight Hundred Thirty Three dollars ($595,833).  The aggregate amount set forth in the preceding sentence shall be paid in equal installments over a period of thirteen (13) months on the regular payroll dates of the Company minus required tax withholdings&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Company shall pay to Executive, in equal monthly installments (and subject to applicable tax and other withholdings), an amount equal to the premium payments for continuing medical, dental and vision coverage for Executive (and Executive&#8217;s family, if covered under Company&#8217;s group health plan as of the Employment Termination Date pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA) for the eighteen (18)-month period following the Employment Termination Date, but only to the extent Executive and Executive&#8217;s family elects and remains entitled to COBRA continuation coverage during such time period&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Company shall pay to Executive, on the first regular payroll date of the Company after the expiration of the Revocation Period, an amount equal to Fifty Two Thousand Seven Hundred Thirty Nine dollars ($52,739), which represents Executive&#8217;s accrued and unpaid vacation days through the Employment Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive acknowledges and agrees that rights and consideration set forth in this Section 5 consist of rights and consideration to which Executive would not otherwise be entitled in the absence of this Agreement and in the absence of the releases of Executive set forth herein. Executive agrees and acknowledges that, as of the Employment Termination Date and thereafter, Executive will be entitled to no compensation other than (x) accrued and unpaid salary and benefits at the rate set forth in the Employment Agreement through the Employment Termination Date (&#8220;Accrued Compensation&#8221;), and (y) the rights set forth in this Section 5.  The Company agrees that, in the event of a Change of Control (as defined in the Employment Agreement) of the Company hereafter, any amounts that remain unpaid in this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Section 5 as of the date of the closing of the Change of Control shall be paid in full upon the closing of such Change of Control.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Survival of Certain Obligations&#59; Updating of Social Media Accounts&#59; Continuing Obligations under Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Notwithstanding the termination of Executive&#8217;s employment and the termination of the Employment Agreement, Executive agrees and acknowledges that all of the Continuing Obligations shall remain in full force and effect at all times hereafter (including after the Effective Date and Employment Termination Date). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive agrees that within five (5) business days following the Employment Termination Date, Executive will update her accounts or profiles on any social media platform (including, but not limited to, Facebook, X, or LinkedIn) to reflect that Executive is no longer employed by or affiliated with the Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Executive acknowledges, understands, and agrees that&#58;  (i) for purposes of Rule 144 under the Securities Act of 1933, as amended, she will be deemed an &#8220;affiliate&#8221; of the Company for a period of ninety (90) days following the Employment Termination Date, (ii) she may, following the Employment Termination Date, continue to have certain obligations and liabilities under Section 16 of the Securities Exchange Act of 1934 Act, as amended, and Executive agrees to comply with the applicable provisions of said Section 16, and (iii) Executive may continue to be in possession of material nonpublic information regarding the Company for an indefinite period of time following the Employment Termination Date and that she will, in fact, be deemed to be in possession of material nonpublic information regarding the Company, and Executive agrees to comply with all laws, rules, and regulations regarding trading securities of an issuer while in possession of material nonpublic information of such issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Filed Claim</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive agrees that Executive has not suffered any on-the-job injury for which Executive has not already filed a claim. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Releases and Waivers of Claims</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. In consideration for the compensation set forth in Section 5 hereof and the other agreements of the Company herein, Executive hereby unconditionally and irrevocably releases, waives and forever discharges the Company and all past and present parents, successors in interests and assigns, affiliates, subsidiaries, divisions, departments, wholly-owned corporations or partnerships, business associations, sole proprietorships, insurers and its current or former officers, agents, representatives, attorneys, fiduciaries, administrators, directors, stockholders, members, partners, or employees, in both their individual and official capacities (herein collectively referred to as &#8220;Released Parties&#8221;), of and from, and agrees not to sue and not to assert against them, any causes of action, claims and demands whatsoever, known or unknown, at law, in equity, or before any agency or commission of local, state and federal governments, arising, alleged to have arisen, or which might have been alleged to have arisen, or which may arise under any law, rule, or regulation, including, but not limited to, the Civil Rights Act of 1886, 1871, 1964, and 1991&#59; 42 U.S.C. Section 1981&#59; the Age Discrimination in Employment Act&#59; the Equal Pay Act&#59; the Employee Retirement Income Security Act&#59; the Americans with Disabilities Act&#59; the Family and Medical Leave Act&#59; the National Labor Relations Act&#59; the Immigration Reform and Control Act of 1986&#59; the Worker Adjustment Retraining and Notification Act&#59; the Occupational Safety and Health Act&#59; the Consolidated Omnibus Budget Reconciliation Act&#59; the Florida Civil Rights Act of 1992&#59; the Florida Minimum Wage Act&#59; the Genetic Information Nondisclosure Act&#59;  the Florida Whistle-Blower&#8217;s Act&#59; Sections 440.205 and 448.101-105, Florida Statutes&#59;  the New York Civil Rights Law, Section 125 of the New York Workers' Compensation Law, Article 23-A of the New York Correction Law, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">New York City Human Rights Law, as amended by the New York City Pregnant Workers Fairness Act, and the New York City Earned Safe and Sick Time Act and any similar New York or other state or federal statute ,and any other statutory, common law, or public policy claim, whether in tort (including without limitation any claim for assault, battery, intentional infliction of emotional distress, invasion of privacy, negligence, or negligent hiring, retention, or supervision) or contract including but not limited to any claims of any breach of any prior letters or employment agreements with the Company&#59; whether federal, state, or local&#59; whether at law or in equity&#59; including attorney fees, costs, and expenses, to the date of this Agreement. Executive expressly intends this release to reach to the maximum extent permitted by law. Notwithstanding this provision, expressly excluded from this release, are any of the Company&#8217;s obligations to Executive pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE UNDERSTANDS THAT THIS AGREEMENT RELEASES ALL CLAIMS BASED ON FACTS OR OMISSIONS OCCURRING ON OR BEFORE THE DATE OF THIS AGREEMENT, EVEN IF EXECUTIVE DOES NOT, AT THE TIME EXECUTIVE SIGNS THIS AGREEMENT, HAVE KNOWLEDGE OF THOSE FACTS OR OMISSIONS.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Challenge to Enforceability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive agrees that this Agreement was reached after she had sufficient time to consult with her legal counsel, Paul Hastings, LLP, and any other attorney she may have chosen to consult with.  Executive therefore waives any claim that she was coerced in any way to enter into this Agreement.  Executive understands that nothing contained in this Agreement limits Executive&#8217;s ability to file a charge or complaint with the Equal Employment Opportunity Commission (&#8220;EEOC&#8221;), the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (&#8220;Government Agencies&#8221;).  Executive further understands that this Agreement does not limit Executive&#8217;s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  This Agreement does not limit Executive&#8217;s right to receive an award for information provided to any Government Agencies.  Nothing in this Agreement shall prevent Executive&#8217;s participation in any legal proceedings against the Company or any Released Party in compliance with a summons that requires such participation, or Executive&#8217;s initiation of or participation in administrative proceedings or investigations of the EEOC or other Government Agencies&#59; provided, however, that this Agreement shall prevent Executive from receiving any monetary or financial damages or recoveries from the Company or any Released Party or reinstatement with the Company in connection with any such proceedings or investigations which is not based on recovering or receiving an award paid by a Government Agency. Executive represents that Executive has not filed or asserted any claims whatsoever against the Company or any Released Party.  Nothing contained in this Agreement shall prevent either Party from bringing any claim for breach or to otherwise take legal action to enforce this Agreement&#8217;s terms in accordance with the provisions hereof. Further, Executive does not release any claims for indemnification under the Indemnification Rights.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defend Trade Secrets Act Disclaimer&#59; Other Statements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Nothing in this Agreement is intended to discourage or restrict Executive from reporting any theft of trade secrets pursuant to the Defend Trade Secrets Act of 2016 (the &#8220;DTSA&#8221;) or other applicable state or federal law.&#160; The DTSA prohibits retaliation against an employee because of whistleblower activity in connection with the disclosure of trade secrets, so long as any such disclosure is made either (i) in confidence to an attorney or a federal, state, or local government official and solely to report or investigate a suspected violation of the law, or (ii) under seal in a complaint or other document filed in a lawsuit or other proceeding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;If Executive believes that any employee or any third party has misappropriated or improperly used or disclosed trade secrets or confidential information, Executive should report such activity to the Company&#8217;s Chair of the Board. This Agreement is in addition to and not in lieu of any obligations to protect the Company&#8217;s trade secrets and confidential information which otherwise exists. Nothing in this Agreement shall limit, curtail or diminish the Company&#8217;s statutory rights under the DTSA, any applicable state law regarding trade secrets or common law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Nothing contained in this Agreement or in the Continuing Obligations shall be deemed to prevent Executive from disclosing any information or facts concerning matters Executive reasonably believes to be illegal discrimination, illegal harassment&#59; illegal retaliation&#59; a wage and hour violation&#59; or sexual assault or is recognized as against a clear public policy mandate.  In addition, notwithstanding the continuing obligations in Section 14 of the Employment Agreement, nothing shall prohibit Executive from making truthful statements in connection with a legal proceeding, and nothing in Section 14 prohibits Executive from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Executive has reason to believe is unlawful.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt from Section 409A of the Internal Revenue Code, and the regulations and guidance promulgated thereunder and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law&#59; Venue&#59; Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be subject to and governed by the laws of the State of  Florida, without giving effect to the principles of conflicts of law under  Florida law that would require or permit the application of the laws of a jurisdiction other than the State of  Florida and irrespective of the fact that the Parties now or at any time may be residents of or engage in activities in a different state. Executive agrees that in the event of any dispute or claim arising under this Agreement and subject to Section 13 below, jurisdiction and venue shall be vested and proper, and Executive hereby consents to the jurisdiction of any court sitting in, Palm Beach County, Florida, including the United States District Court for the Southern District of Florida.  THE PARTIES HEREBY WAIVE A JURY TRIAL IN ANY LITIGATION ARISING UNDER OR RELATING TO THIS AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Arbitration of Disputes</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise prohibited by law or specified below, all disputes, claims and causes of action, in law or equity, arising from or relating to this Agreement or its enforcement, performance, breach, or interpretation shall be resolved pursuant to the Dispute Resolution provisions set forth in Section 10 of the Employment Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement incorporates the entire understanding among the Parties with respect to the subject matter hereof.  In reaching the agreements in this Agreement, neither Party has relied upon any representation or promise, oral or written, except those set forth herein. This Agreement has been duly authorized by the Parties and duly executed on behalf of each Party by the duly authorized officers or principals and in the manner required by all laws and regulations applicable to each such entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterpart Signatures</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement may be executed in one or more counterparts, and by the Parties in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute the same agreement. The Parties further agree that facsimile signatures or signatures scanned into .pdf (or similar) format and sent by e-mail shall be deemed original signatures.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be binding upon and inure solely to the benefit of each Party identified herein, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.  The Company may assign this Agreement to any successors (whether direct or indirect, by purchase, merger, consolidation or otherwise) to the business and&#47;or assets of the Company. In as much as the duties of Executive hereunder are personal in nature, she may not assign this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event any provision of this Agreement shall be held invalid or unenforceable, it shall be deemed modified, only to the extent necessary to make it lawful.  To effect such modification, the said provision shall be deemed deleted, added to and&#47;or rewritten, whichever shall most fully preserve the intentions of the Parties as originally expressed herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-disparagement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive will at all times hereafter comply with Section 14 of the Employment Agreement.  The Company agrees that it will instruct the members of its board of directors and its executive officers not to publish or communicate in any way any information or opinions intended to damage or otherwise disparage the reputations of Executive&#59; provided, however, that nothing herein shall restrict the Company or any officer, director, or employee thereof from making truthful statements in connection with a legal proceeding, government investigation, filings with the U.S. Securities and Exchange Commission, or in communications with the Company&#8217;s current or future auditor.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary Execution</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive represents that Executive has read this Agreement in its entirety and has had the opportunity to consult with legal counsel prior to signing this Agreement and that Executive is fully aware of its contents and of its legal effect.  Executive signs this Agreement of Executive&#8217;s own free will and act, without any legal reservations, duress, coercion or undue influence, and it is Executive&#8217;s intention that Executive be legally bound hereby.  Executive is hereby advised she has the right to consult with an attorney of her own choosing before entering into this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Period to Consider and Revoke</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. Executive acknowledges that Executive was offered the opportunity to consider this Agreement for a period of twenty-one (21) days from the time Executive received it on August 8 2025.  After consultation with her attorney, the Executive has voluntarily agreed to execute the Agreement in less than the 21-day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE AGREES THAT ANY MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT AFTER THE EFECTIVE DATE DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive can revoke this Agreement at any time during the seven (7) days after signing it (the &#8220;Revocation Period&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Acceptance and&#47;or Revocation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">IMPORTANT NOTICE TO EXECUTIVE</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  Executive may accept this Agreement by signing it and returning it to the Company.  Executive may exercise her right to revoke her decision to sign this Agreement by sending a written notice of revocation to the individual at the email address specified below by no later than the last day of the Revocation Period stated in Section 20 above&#58;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Leslie Campbell, Chair of Board of Directors</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">lcg.campbell&#64;gmail.com</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If Executive exercises her right to revoke, her termination of employment shall be deemed to be a Voluntary Resignation without Good Reason, as those terms are defined in the Employment Agreement, in which case she will receive only her Accrued Compensation through the date of termination, and she </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">will be entitled to no other benefits or compensation hereunder (including no further rights under Sections 4 or 5 hereof) under the Employment Agreement or otherwise.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#91;signatures follow&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Parties have duly executed this Transition and Separation Agreement as of the date first written above.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">by&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Leslie C.G Campbell</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Leslie C.G. Campbell</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Chair, Board of Directors</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Sandra Campos</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Sandra Campos, individually &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Date of Signature&#58;  August 11, 2025</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><div id="icba043f48db54433862d4e9757519ff2_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EXHIBIT A<br>to Separation Agreement</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Parties acknowledge that the Company and Executive are currently parties to the following equity award agreements (the &#8220;Equity Award Agreements&#8221;)&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;a Restricted Stock Unit Agreement, dated August 3, 2023 (the &#8220;2023 RSU Agreement&#8221;), pursuant to which Executive was granted (in her capacity as a non-employee director) 7,500 restricted stock units (&#8220;RSUs&#8221;) of the Company under the Company&#8217;s 2015 Director Equity Compensation  Plan (the &#8220;2015 Plan&#8221;) upon the terms and conditions set forth in the 2023 RSU Agreement and the 2015 Plan, of which 5,000  RSUs are vested and 2,500 RSUs are unvested (the &#8220;Unvested 2023 RSUs&#8221;) as of the date of this Agreement,</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;a Restricted Stock Unit Agreement, dated April 29, 2024 (the &#8220;2024 RSU Agreement&#8221;), pursuant to which Executive was granted 483,092 RSUs under the Company&#8217;s 2022 Employee Equity Compensation Plan (the &#8220;2022 Plan&#8221;) upon the terms and conditions set forth in the 2024 RSU Agreement and the 2022 Plan, of which 161,030 RSUs are vested and 322,062 RSUs are unvested (the &#8220;Unvested 2024 RSUs&#8221;) as of the date of this Agreement,</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;a Restricted Stock Unit Award, dated January 15, 2025 (the &#8220;2025 RSU Agreement&#8221;), pursuant to which Executive was granted 146,772 RSUs under the Company&#8217;s 2024 Omnibus Incentive Plan (the &#8220;2024 Plan&#8221;) upon the terms and conditions set forth in the 2025 RSU Agreement and the 2024 Plan, of which all 146,772 RSUs are unvested (the &#8220;Unvested 2025 RSUs&#8221;) as of the date of this Agreement, and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;a Performance Stock Unit Award, dated January 15, 2025 (the &#8220;2025 PSU Agreement&#8221;), pursuant to which Executive was granted 146,772 Performance Stock Units (&#8220;PSUs&#8221;) under the 2024 Plan upon the terms and conditions set forth in the 2025 PSU Agreement and the 2024 Plan, none of which PSUs have vested as of the date of this Agreement.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Parties agree and acknowledge that&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Upon the first day following the expiration of the Revocation Period and only if Executive has not revoked this Agreement pursuant to Section 20 or 21 of this Agreement, (a) 281 of the Unvested 2023 RSUs shall vest and 2,219 of the Unvested 2023 RSUs shall be forfeited, (b)  60,002 of the Unvested 2024 RSUs shall vest and 262,060 of the Unvested 2024 RSUs shall be forfeited, and (c) 32,170 of the Unvested 2025 RSUs shall vest and 114,602 of the Unvested 2025 RSUs shall be forfeited.  Executive and the Company hereby agree that the tax withholding requirement related to the foregoing vesting of RSUs shall be satisfied by the Company withholding for its own account the number of shares otherwise deliverable to the Executive having an aggregate </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Fair Market Value (as defined in the 2024 Plan) on the date the tax is to be determined equal to the tax that the Company must withhold in connection with such vesting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;None of the PSUs have vested and all PSUs are forfeited as of the date of this Agreement, and the PSA Agreement is hereby terminated.  </font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Executive acknowledges that, except for the Equity Award Agreements described above and subject to the terms and conditions described above, she does not hold and is not entitled to any options, restricted shares, performance shares, restricted stock units, performance stock units, or other equity awards from the Company under the Employment Agreement or otherwise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>pets-deliaexecseparationag.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ia13ae7d24f104c3caef1a2372f740cf3_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">SEPARATION AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;THIS SEPARATION AGREEMENT </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;Agreement&#8221;) is dated as of August 11, 2025 (the &#8220;Effective Date&#8221;), by and between Robyn D&#8217;Elia, an individual (&#8220;Executive&#8221;), and PETMED EXPRESS, INC., a Florida corporation whose principal place of business is located at 420 South Congress Avenue, Delray Beach, FL 33445 (the &#8220;Company&#8221;). The Company and Executive are sometimes individually referred to in this Agreement as a &#8220;Party&#8221; and collectively as the &#8220;Parties.&#8221;  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">RECITALS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;Executive is currently employed by the Company as the Company&#8217;s Chief Financial Officer, and in connection therewith, the Company and Executive are parties to an Executive Employment Agreement with an effective date of September 16, 2024 (the &#8220;Employment Agreement&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;Executive and the Company desire to hereby set forth certain mutual agreements and understandings relating to the separation of Executive from the Company as set forth below in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">NOW THEREFORE, in consideration of the mutual promises set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, do hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">TERMS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Recitals</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  The foregoing Recitals are true and correct and are incorporated into this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Executive agrees that she has voluntarily resigned from her employment with the Company and its subsidiaries effective as of the close of business on August 11, 2025 (the &#8220;Employment Termination Date&#8221;). The Parties agree this Agreement shall constitute notice of said termination as set forth in Sections 4(iv) and 8 of the Employment Agreement. Executive hereby irrevocably waives any right to receive any advance notice of termination as set forth in Section 4(iv) of the Employment Agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Executive agrees that the Employment Agreement is terminated effective as of the Employment Termination Date and that neither Executive nor the Company will have any further rights or obligations under the Employment Agreement, provided that such termination of the Employment Agreement shall not affect (i) Executive&#8217;s obligations under, and the provisions set forth in, Sections 5, 9, 10, 14, 18 of the Employment Agreement, which shall remain in full force and effect after the Employment Termination Date in accordance with the terms and provisions thereof (such obligations of Executive, the &#8220;Continuing Obligations&#8221;), (ii) Executive&#8217;s indemnification rights (and the Company&#8217;s corresponding indemnification obligations) pursuant to and in accordance with (A) the indemnification provisions of Sections 607.0850 through 607.0859 of the Florida Business Corporation Act, and (B) Article 9 of the Company&#8217;s Third Amended and Restated Bylaws (collectively, the &#8220;Indemnification Rights&#8221;).  Executive also agrees that she will at all times after the Effective Date and Employment Termination Date continue to be subject to the PetMed Express, Inc. Executive Compensation Recovery Policy.  Notwithstanding clause (i) of the preceding, the covenant set forth in the first two sentences of Section 5(b) of the Employment Agreement shall not be a Continuing Obligation after the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">expiration of the Consulting Period (as defined below) and shall terminate effective as of the end of the Consulting Period, provided that all other obligations in Section 5 of the Employment Agreement shall survive the expiration of the Consulting Period and constitute a Continuing Obligation at all times.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive hereby resigns, as of the Employment Termination Date, from the offices of Chief Financial Officer, and from all other offices, directorships, manager positions, trusteeships, committee memberships and fiduciary and other capacities held with, or on behalf of, the Company and its direct and indirect subsidiaries, and Executive&#8217;s execution of this Agreement will be deemed the </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">grant</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> by Executive to the officers of the Company of a limited power of attorney to sign in Executive&#8217;s name and on Executive&#8217;s behalf any such documentation as may be required to be executed solely for the limited purposes of effectuating such resignations.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Post-Termination Consulting Services&#59; Cooperation and Assistance</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;In consideration of and as an inducement to the Company entering into this Agreement when not otherwise obligated to do so, Executive agrees that she will, during the three-month period commencing on the Employment Termination Date (the &#8220;Consulting Period&#8221;), provide the Company, on an as-needed and as-requested basis, such consulting services as the Company may from time to time reasonably request relating to matters that were within the purview of Executive&#8217;s role and duties to the Company during her employment (the &#8220;Consulting Services&#8221;), up to a maximum of five (5) hours of Consulting Services during each calendar week during the Consulting Period.  The Consulting Services shall be rendered remotely and may include, without limitation and at the request of the Company, being available by email, through internet connection, and by telephone during normal business hours during ordinary business days, to answer questions and provide information and assistance relating to, and to otherwise cooperate with the Company and its management with respect to, transitional matters and other matters that Executive was involved with during the term of her employment with the Company.  The Consulting Services shall be rendered for no additional compensation other than payment of the compensation described in Section 5 below.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;In addition to the Consulting Services and in consideration of the benefits provided for in Section 5 below, Executive agrees to reasonably cooperate with the Company and any of the Released Parties (as defined below) as to any current or future litigation, internal investigations, information inquiry, or contractual disputes on matters in which she was involved or about which Executive gained knowledge while an employee or director of the Company. This duty of cooperation shall include, but shall not be limited to&#58; (a) meeting with the Company&#8217;s or the Released Parties&#8217; attorneys by telephone or in person at mutually convenient times and places in order to state truthfully Executive&#8217;s knowledge of the matters at issue and recollection of events (including an initial meeting to be held within 24 hours of the time that this Agreement is executed)&#59; and (b) signing, at Company&#8217;s, Released Parties&#8217;, or their attorneys&#8217; request, declarations or affidavits that truthfully state the matters of which Employee has knowledge. General information or background inquiries will be answered by the Executive within two (2) business days. When it seeks future cooperation, the Company will endeavor to avoid disrupting or interfering with the Executive&#8217;s future employment or future business or personal obligations, and the Executive will not unnecessarily or unreasonably claim or assert interference with her future business or personal obligations.  The Company agrees to reimburse Executive for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">reasonable out-of-pocket expenses (including reasonable attorneys&#8217; fees pursuant to the Indemnification Rights) incurred at the request of the Company with respect to this Section 3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Outstanding Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. The Parties agree and acknowledge that the outstanding equity awards held by Executive shall be treated in the manner set forth on </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> hereto, which is incorporated into this Agreement by this reference.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consideration.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">  In consideration of Executive&#8217;s agreements, releases, and covenants set forth in this Agreement, so long as (i) Executive does not revoke this Agreement pursuant Sections 20 or 21 of this Agreement (and no payments hereunder shall be due until the expiration of the Revocation Period, as defined below), and (ii) Executive complies with the terms and provisions of this Agreement, Executive will be entitled to the following compensation&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Payment of an amount equal to the sum of (i) Four Hundred Twenty-Five Thousand Dollars ($425,000), which is the equivalent of twelve (12) months of Executive&#8217;s current Base Salary (as defined in the Employment Agreement) plus (ii) an additional Thirty Five Thousand Four Hundred Seventeen dollars ($35,417) in lieu of the notice period contemplated by Section 4(iv) of the Employment Agreement, for an aggregate of Four Hundred Sixty Thousand Four Hundred Seventeen dollars ($460,617).  The aggregate amount set forth in the preceding sentence shall be paid in equal installments over a period of thirteen (13) months on the regular payroll dates of the Company minus required tax withholdings&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Company shall pay to Executive, in equal monthly installments (and subject to applicable tax and other withholdings), an amount equal to the premium payments for continuing medical, dental and vision coverage for Executive (and Executive&#8217;s family, if covered under Company&#8217;s group health plan as of the Employment Termination Date pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA) for the eighteen (18)-month period following the Employment Termination Date, but only to the extent Executive and Executive&#8217;s family elects and remains entitled to COBRA continuation coverage during such time period&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Company shall pay to Executive, on the first regular payroll date of the Company after the expiration of the Revocation Period, an amount equal to Thirty Two Thousand Six Hundred Two dollars ($32,602), which represents Executive&#8217;s accrued and unpaid vacation days through the Employment Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive acknowledges and agrees that rights and consideration set forth in this Section 5 consist of rights and consideration to which Executive would not otherwise be entitled in the absence of this Agreement and in the absence of the releases of Executive set forth herein. Executive agrees and acknowledges that, as of the Employment Termination Date and thereafter, Executive will be entitled to no compensation other than (x) accrued and unpaid salary and benefits at the rate set forth in the Employment Agreement through the Employment Termination Date (&#8220;Accrued Compensation&#8221;), and (y) the rights set forth in this Section 5.  The Company agrees that, in the event of a Change of Control (as defined in the Employment Agreement) of the Company hereafter, any amounts that remain unpaid in this Section 5 as of the date of the closing of the Change of Control shall be paid in full upon the closing of such Change of Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Survival of Certain Obligations&#59; Updating of Social Media Accounts&#59; Continuing Obligations under Securities Laws</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Notwithstanding the termination of Executive&#8217;s employment and the termination of the Employment Agreement, Executive agrees and acknowledges that all of the Continuing Obligations shall remain in full force and effect at all times hereafter (including after the Effective Date and Employment Termination Date). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Executive agrees that within five (5) business days following the Employment Termination Date, Executive will update her accounts or profiles on any social media platform (including, but not limited to, Facebook, X, or LinkedIn) to reflect that Executive is no longer employed by or affiliated with the Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Executive acknowledges, understands, and agrees that&#58;  (i) for purposes of Rule 144 under the Securities Act of 1933, as amended, she will be deemed an &#8220;affiliate&#8221; of the Company for a period of ninety (90) days following the Employment Termination Date, (ii) she may, following the Employment Termination Date, continue to have certain obligations and liabilities under Section 16 of the Securities Exchange Act of 1934 Act, as amended, and Executive agrees to comply with the applicable provisions of said Section 16, and (iii) Executive may continue to be in possession of material nonpublic information regarding the Company for an indefinite period of time following the Employment Termination Date and that she will, in fact, be deemed to be in possession of material nonpublic information regarding the Company, and Executive agrees to comply with all laws, rules, and regulations regarding trading securities of an issuer while in possession of material nonpublic information of such issuer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Filed Claim</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive agrees that Executive has not suffered any on-the-job injury for which Executive has not already filed a claim. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Releases and Waivers of Claims</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. In consideration for the compensation set forth in Section 5 hereof and the other agreements of the Company herein, Executive hereby unconditionally and irrevocably releases, waives and forever discharges the Company and all past and present parents, successors in interests and assigns, affiliates, subsidiaries, divisions, departments, wholly-owned corporations or partnerships, business associations, sole proprietorships, insurers and its current or former officers, agents, representatives, attorneys, fiduciaries, administrators, directors, stockholders, members, partners, or employees, in both their individual and official capacities (herein collectively referred to as &#8220;Released Parties&#8221;), of and from, and agrees not to sue and not to assert against them, any causes of action, claims and demands whatsoever, known or unknown, at law, in equity, or before any agency or commission of local, state and federal governments, arising, alleged to have arisen, or which might have been alleged to have arisen, or which may arise under any law, rule, or regulation, including, but not limited to, the Civil Rights Act of 1886, 1871, 1964, and 1991&#59; 42 U.S.C. Section 1981&#59; the Age Discrimination in Employment Act&#59; the Equal Pay Act&#59; the Employee Retirement Income Security Act&#59; the Americans with Disabilities Act&#59; the Family and Medical Leave Act&#59; the National Labor Relations Act&#59; the Immigration Reform and Control Act of 1986&#59; the Worker Adjustment Retraining and Notification Act&#59; the Occupational Safety and Health Act&#59; the Consolidated Omnibus Budget Reconciliation Act&#59; the Florida Civil Rights Act of 1992&#59; the Florida Minimum Wage Act&#59; the Genetic Information Nondisclosure Act&#59;  the Florida Whistle-Blower&#8217;s Act&#59; Sections 440.205 and 448.101-105, Florida Statutes&#59;  the New York Civil Rights Law, Section 125 of the New York Workers' Compensation Law, Article 23-A of the New York Correction Law, the New York City Human Rights Law, as amended by the New York City Pregnant Workers Fairness Act, and the New York City Earned Safe and Sick Time Act,  the New Jersey Law Against Discrimination (NJLAD), the New Jersey Family Leave Act (NJFLA), the New Jersey Conscientious Employee Protection Act (NJCEPA), the New Jersey Wage Payment Law, the New Jersey Wage and Hour Law, retaliation claims under the New Jersey Workers' Compensation Law (NJWCL), the New Jersey Equal Pay Act, the New Jersey Security and Financial Empowerment Act (SAFE Act), the New Jersey Temporary Disability Benefits Law, the New Jersey Earned Sick </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Leave Law, and any similar New York or other state or federal statute ,and any other statutory, common law, or public policy claim, whether in tort (including without limitation any claim for assault, battery, intentional infliction of emotional distress, invasion of privacy, negligence, or negligent hiring, retention, or supervision) or contract including but not limited to any claims of any breach of any prior letters or employment agreements with the Company&#59; whether federal, state, or local&#59; whether at law or in equity&#59; including attorney fees, costs, and expenses, to the date of this Agreement. Executive expressly intends this release to reach to the maximum extent permitted by law. Notwithstanding this provision, expressly excluded from this release, are any of the Company&#8217;s obligations to Executive pursuant to this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE UNDERSTANDS THAT THIS AGREEMENT RELEASES ALL CLAIMS BASED ON FACTS OR OMISSIONS OCCURRING ON OR BEFORE THE DATE OF THIS AGREEMENT, EVEN IF EXECUTIVE DOES NOT, AT THE TIME EXECUTIVE SIGNS THIS AGREEMENT, HAVE KNOWLEDGE OF THOSE FACTS OR OMISSIONS.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Challenge to Enforceability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive agrees that this Agreement was reached after she had sufficient time to consult with her legal counsel, Paul Hastings, LLP, and any other attorney she may have chosen to consult with.  Executive therefore waives any claim that she was coerced in any way to enter into this Agreement.  Executive understands that nothing contained in this Agreement limits Executive&#8217;s ability to file a charge or complaint with the Equal Employment Opportunity Commission (&#8220;EEOC&#8221;), the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (&#8220;Government Agencies&#8221;).  Executive further understands that this Agreement does not limit Executive&#8217;s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  This Agreement does not limit Executive&#8217;s right to receive an award for information provided to any Government Agencies.  Nothing in this Agreement shall prevent Executive&#8217;s participation in any legal proceedings against the Company or any Released Party in compliance with a summons that requires such participation, or Executive&#8217;s initiation of or participation in administrative proceedings or investigations of the EEOC or other Government Agencies&#59; provided, however, that this Agreement shall prevent Executive from receiving any monetary or financial damages or recoveries from the Company or any Released Party or reinstatement with the Company in connection with any such proceedings or investigations which is not based on recovering or receiving an award paid by a Government Agency. Executive represents that Executive has not filed or asserted any claims whatsoever against the Company or any Released Party.  Nothing contained in this Agreement shall prevent either Party from bringing any claim for breach or to otherwise take legal action to enforce this Agreement&#8217;s terms in accordance with the provisions hereof. Further, Executive does not release any claims for indemnification under the Indemnification Rights.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Defend Trade Secrets Act Disclaimer&#59; Other Statements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Nothing in this Agreement is intended to discourage or restrict Executive from reporting any theft of trade secrets pursuant to the Defend Trade Secrets Act of 2016 (the &#8220;DTSA&#8221;) or other applicable state or federal law.&#160; The DTSA prohibits retaliation against an employee because of whistleblower activity in connection with the disclosure of trade secrets, so long as any such disclosure is made either (i) in confidence to an attorney or a federal, state, or local government official and solely to report or investigate a suspected violation of the law, or (ii) under seal in a complaint or other document filed in a lawsuit or other proceeding.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;If Executive believes that any employee or any third party has misappropriated or improperly used or disclosed trade secrets or confidential information, Executive should report </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">such activity to the Company&#8217;s Chair of the Board. This Agreement is in addition to and not in lieu of any obligations to protect the Company&#8217;s trade secrets and confidential information which otherwise exists. Nothing in this Agreement shall limit, curtail or diminish the Company&#8217;s statutory rights under the DTSA, any applicable state law regarding trade secrets or common law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Nothing contained in this Agreement or in the Continuing Obligations shall be deemed to prevent Executive from disclosing any information or facts concerning matters Executive reasonably believes to be illegal discrimination, illegal harassment&#59; illegal retaliation&#59; a wage and hour violation&#59; or sexual assault or is recognized as against a clear public policy mandate.  In addition, notwithstanding the continuing obligations in Section 14 of the Employment Agreement, nothing shall prohibit Executive from making truthful statements in connection with a legal proceeding, and nothing in Section 14 prohibits Executive from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Executive has reason to believe is unlawful.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt from Section 409A of the Internal Revenue Code, and the regulations and guidance promulgated thereunder and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be in compliance therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law&#59; Venue&#59; Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be subject to and governed by the laws of the State of  Florida, without giving effect to the principles of conflicts of law under  Florida law that would require or permit the application of the laws of a jurisdiction other than the State of  Florida and irrespective of the fact that the Parties now or at any time may be residents of or engage in activities in a different state. Executive agrees that in the event of any dispute or claim arising under this Agreement and subject to Section 13 below, jurisdiction and venue shall be vested and proper, and Executive hereby consents to the jurisdiction of any court sitting in, Palm Beach County, Florida, including the United States District Court for the Southern District of Florida.  THE PARTIES HEREBY WAIVE A JURY TRIAL IN ANY LITIGATION ARISING UNDER OR RELATING TO THIS AGREEMENT.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Arbitration of Disputes</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Unless otherwise prohibited by law or specified below, all disputes, claims and causes of action, in law or equity, arising from or relating to this Agreement or its enforcement, performance, breach, or interpretation shall be resolved pursuant to the Dispute Resolution provisions set forth in Section 10 of the Employment Agreement. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement incorporates the entire understanding among the Parties with respect to the subject matter hereof.  In reaching the agreements in this Agreement, neither Party has relied upon any representation or promise, oral or written, except those set forth herein. This Agreement has been duly authorized by the Parties and duly executed on behalf of each Party by the duly authorized officers or principals and in the manner required by all laws and regulations applicable to each such entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Counterpart Signatures</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement may be executed in one or more counterparts, and by the Parties in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute the same agreement. The Parties further agree that facsimile signatures or signatures scanned into .pdf (or similar) format and sent by e-mail shall be deemed original signatures.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be binding upon and inure solely to the benefit of each Party identified herein, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.  The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Company may assign this Agreement to any successors (whether direct or indirect, by purchase, merger, consolidation or otherwise) to the business and&#47;or assets of the Company. In as much as the duties of Executive hereunder are personal in nature, she may not assign this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  In the event any provision of this Agreement shall be held invalid or unenforceable, it shall be deemed modified, only to the extent necessary to make it lawful.  To effect such modification, the said provision shall be deemed deleted, added to and&#47;or rewritten, whichever shall most fully preserve the intentions of the Parties as originally expressed herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-disparagement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive will at all times hereafter comply with Section 14 of the Employment Agreement.  The Company agrees that it will instruct the members of its board of directors and its executive officers not to publish or communicate in any way any information or opinions intended to damage or otherwise disparage the reputations of Executive&#59; provided, however, that nothing herein shall restrict the Company or any officer, director, or employee thereof from making truthful statements in connection with a legal proceeding, government investigation, filings with the U.S. Securities and Exchange Commission, or in communications with the Company&#8217;s current or future auditor.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Voluntary Execution</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive represents that Executive has read this Agreement in its entirety and has had the opportunity to consult with legal counsel prior to signing this Agreement and that Executive is fully aware of its contents and of its legal effect.  Executive signs this Agreement of Executive&#8217;s own free will and act, without any legal reservations, duress, coercion or undue influence, and it is Executive&#8217;s intention that Executive be legally bound hereby.  Executive is hereby advised she has the right to consult with an attorney of her own choosing before entering into this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Period to Consider and Revoke</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">. Executive acknowledges that Executive was offered the opportunity to consider this Agreement for a period of twenty-one (21) days from the time Executive received it on August 8, 2025.  After consultation with her attorney, the Executive has voluntarily agreed to execute the Agreement in less than the 21-day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE AGREES THAT ANY MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT AFTER THE EFFECTIVE DATE DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  Executive can revoke this Agreement at any time during the seven (7) days after signing it (the &#8220;Revocation Period&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Acceptance and&#47;or Revocation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">IMPORTANT NOTICE TO EXECUTIVE</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  Executive may accept this Agreement by signing it and returning it to the Company.  Executive may exercise her right to revoke her decision to sign this Agreement by sending a written notice of revocation to the individual at the email address specified below by no later than the last day of the Revocation Period stated in Section 20 above&#58;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Leslie Campbell, Chair of Board of Directors</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">lcg.campbell&#64;gmail.com</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">If Executive exercises her right to revoke, her termination of employment shall be deemed to be a Voluntary Resignation without Good Reason, as those terms are defined in the Employment Agreement, in which case she will receive only her Accrued Compensation through the date of termination, and she will be entitled to no other benefits or compensation hereunder (including no further rights under Sections 4 or 5 hereof) under the Employment Agreement or otherwise.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">&#91;signatures follow&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Parties have duly executed this Transition and Separation Agreement as of the date first written above.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Leslie C.G. Campbell</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58;  Leslie C.G. Campbell</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Chair, Board of Directors</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Robyn D&#8217;Elia</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Robyn D&#8217;Elia, individually &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">Date of Signature&#58;  August 11, 2025</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div><div id="ia13ae7d24f104c3caef1a2372f740cf3_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">EXHIBIT A<br>to Separation Agreement</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:400;line-height:120%">The Parties acknowledge and agree that the Company and Executive are currently parties a Restricted Stock Unit Award, dated September 24, 2024 (the &#8220;2024 RSU Agreement&#8221;), pursuant to which Executive was granted 250,000 restricted stock units (&#8220;RSUs&#8221;) under the Company&#8217;s 2024 Inducement Incentive Plan (the &#8220;2024 Plan&#8221;) upon the terms and conditions set forth in the 2024 RSU Agreement and the 2024 Plan, of which all 250,000 RSUs are unvested (the &#8220;Unvested 2025 RSUs&#8221;) as of the date of this Agreement.  The Parties further agree that, upon the first day following the expiration of the Revocation Period and only if Executive has not revoked this Agreement pursuant to Section 19 or 20 of this Agreement, 81,735 the Unvested 2024 RSUs shall vest and 168,265 of the Unvested 2024 RSUs shall be forfeited. Executive and the Company hereby agree that the tax withholding requirement related to the foregoing vesting of RSUs shall be satisfied by the Company withholding for its own account the number of shares otherwise deliverable to the Executive having an aggregate Fair Market Value (as defined in the 2024 Plan) on the date the tax is to be determined equal to the tax that the Company must withhold in connection with such vesting.  Executive acknowledges that, except for the 2024 RSU Agreement and subject to the foregoing, she does not hold and is not entitled to any options, restricted shares, performance shares, restricted stock units, performance stock units, or other equity awards from the Company under the Employment Agreement or otherwise.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4933-0368-2141.1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>pets-20250812xexx991pressr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i2620ed6cb6114038b2cdea198199ffa2_1"></div><div style="min-height:72pt;width:100%"><div style="padding-right:-6.75pt"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-right:-7pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">EXHIBIT 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">PetMed Express, Inc. Announces Management Changes</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Delray Beach, Florida, August 12, 2025</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">, PetMed Express, Inc. (the &#8220;Company&#8221;) dba PetMeds and parent company of PetCareRx (NASDAQ&#58; PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D&#8217;Elia, have resigned from their positions and employment with the Company.     </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">As part of the leadership changes, Leslie C.G. Campbell, the Chair of the Company&#8217;s Board of Directors (the &#8220;Board&#8221;), has assumed the role of Interim Chief Executive Officer, and Douglas Krulik, the Company&#8217;s Chief Accounting Officer, has assumed the role of Interim Principal Financial Officer.  The Company has initiated a search for a new Chief Executive Officer and Chief Financial Officer.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In connection with their resignations from the Company, Ms. Campos and Ms. D&#8217;Elia each entered into a separation agreement with the Company on August 11, 2025 under which, in exchange for a general release and waiver of claims against the Company, they will receive severance payments in the form of continuation of their current base salary for thirteen months and the accelerated vesting of a portion of their unvested restricted stock units substantially in accordance with the severance terms of their respective employment agreements. They have also agreed to provide consulting services to the Company for a period of three months on an as-needed basis.  A more detailed summary of the terms of the separation agreements is set forth in the Current Report on Form 8-K filed by the Company today with the SEC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Company also announced that, in connection with her resignation, Ms. Campos resigned as a member of the Board of Directors effective as of August 11, 2025, whereupon the Board reduced the number of directors on the Board to five members if and until the Board determines to appoint or nominate additional directors.  Following her transition to Interim Chief Executive Officer, Ms. Campbell will remain as Chair of the Board of Directors but will resign from both the Board&#8217;s Audit Committee and the Compensation and Human Capital Committee.  Justin Mennen has been appointed by the Board as its Lead Independent Director.  In addition, Peter Batushansky has been appointed to Chair of the Board&#8217;s Audit Committee, and Leah Solivan has been appointed to Chair of the Board&#8217;s Compensation and Human Capital Committee.   </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">About PetMed Express, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness and the veterinarians who serve them.  Through its PETS family of brands, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care,  PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:107%">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. Words such as &#8220;may,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;outlook,&#8221; &#8220;strategy,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;seek,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;strive,&#8221; &#8220;goal,&#8221; &#8220;continue,&#8221; &#8220;likely,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar words and expressions are intended to signify forward-looking statements.  These forward-looking statements include, without limitation, statements regarding the management and Board changes described above. Forward-looking statements are based on the Company&#8217;s current expectations and assumptions regarding future events, which are subject to risks and uncertainties. Actual results could differ materially from those anticipated due to a number of factors, including but not limited to, the completion of the ongoing previously announced investigation by the Audit Committee of the Company&#8217;s Board of Directors and other risks described from time to time in the Company&#8217;s filings with the Securities and Exchange Commission, including, but not limited to, the Company's Annual Report on Form 10-K for the year ended March 31, 2024, as well as other subsequent filings on Form 10-Q and periodic filings on Form 8-K. You should not place undue reliance on these forward-looking statements, which apply only as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="padding-right:-6.75pt"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">of the date of this press release and should not be relied upon as representing the Company&#8217;s views as of any subsequent date. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">ICR, LLC</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">John Mills</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Reed Anderson</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">(646) 277-1260</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">investor&#64;petmeds.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>pets-20250811.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:203c903d-b79e-4d7b-8b98-578e1b9f15fc,g:2c359b4f-5c7f-4790-b33d-259153bfdc3e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pets="http://www.1800petmeds.com/20250811" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20250811">
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20250811_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20250811_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20250811_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.1800petmeds.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>pets-20250811_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:203c903d-b79e-4d7b-8b98-578e1b9f15fc,g:2c359b4f-5c7f-4790-b33d-259153bfdc3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20250811.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_05bf34c0-b5a0-4c2e-bf3f-c2b1bff5ecf7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_DocumentInformationTable_05bf34c0-b5a0-4c2e-bf3f-c2b1bff5ecf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d69d9abe-ac7b-43be-b47d-cd829d1491c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_05bf34c0-b5a0-4c2e-bf3f-c2b1bff5ecf7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d69d9abe-ac7b-43be-b47d-cd829d1491c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d69d9abe-ac7b-43be-b47d-cd829d1491c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d69d9abe-ac7b-43be-b47d-cd829d1491c6" xlink:to="loc_us-gaap_ClassOfStockDomain_d69d9abe-ac7b-43be-b47d-cd829d1491c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d69d9abe-ac7b-43be-b47d-cd829d1491c6" xlink:to="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9b5e4df0-17e9-497f-b8f7-997fcef2d805" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:to="loc_us-gaap_CommonStockMember_9b5e4df0-17e9-497f-b8f7-997fcef2d805" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_11597c2d-af72-44e2-a307-02d27230b08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:to="loc_us-gaap_PreferredStockMember_11597c2d-af72-44e2-a307-02d27230b08a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f8f2e879-9532-4530-8ac0-a4a51d4611d2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_DocumentType_f8f2e879-9532-4530-8ac0-a4a51d4611d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8bdf7a93-c7fb-4563-88e5-96effa3ce861" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_DocumentPeriodEndDate_8bdf7a93-c7fb-4563-88e5-96effa3ce861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9501fbf9-3c4e-44ad-8add-b712e39bfbc0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityRegistrantName_9501fbf9-3c4e-44ad-8add-b712e39bfbc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_262266f0-2f14-4848-b434-4550a898fd1d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_262266f0-2f14-4848-b434-4550a898fd1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_97a2591e-66ff-4747-b914-62dde80d003e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityFileNumber_97a2591e-66ff-4747-b914-62dde80d003e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_144d3a38-24e2-4fba-92a8-48c11be361b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityTaxIdentificationNumber_144d3a38-24e2-4fba-92a8-48c11be361b1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f89f223a-6264-41ee-8296-5b668c7b4807" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressAddressLine1_f89f223a-6264-41ee-8296-5b668c7b4807" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b812f980-8b49-41e5-982c-3ff97f5f1ef6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressCityOrTown_b812f980-8b49-41e5-982c-3ff97f5f1ef6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_76616c9a-4d25-435a-82b3-e5f65aedd8b2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressStateOrProvince_76616c9a-4d25-435a-82b3-e5f65aedd8b2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f71d0c99-8f15-4929-abb0-36ce2dbdd96f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressPostalZipCode_f71d0c99-8f15-4929-abb0-36ce2dbdd96f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4b9d2c69-d8b0-4ad4-9d33-b0dfb92fd766" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_CityAreaCode_4b9d2c69-d8b0-4ad4-9d33-b0dfb92fd766" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_77ef755f-35dd-48ee-bba3-4f8b2ca813cf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_LocalPhoneNumber_77ef755f-35dd-48ee-bba3-4f8b2ca813cf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_cac35aa4-5e98-4b40-9eef-bb551ff6f041" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_WrittenCommunications_cac35aa4-5e98-4b40-9eef-bb551ff6f041" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e3ecfc5b-9d3d-4fc5-a3b2-f960fc06f8e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_SolicitingMaterial_e3ecfc5b-9d3d-4fc5-a3b2-f960fc06f8e3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_fce302c0-0d34-4e48-a3d2-fc558ec0c54a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_PreCommencementTenderOffer_fce302c0-0d34-4e48-a3d2-fc558ec0c54a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_3e6cde84-3fb7-48ce-a7a8-58221a2b67c6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_3e6cde84-3fb7-48ce-a7a8-58221a2b67c6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7e85a7b8-ab7e-413f-8abf-56954d849154" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_Security12bTitle_7e85a7b8-ab7e-413f-8abf-56954d849154" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_618b6747-9806-49fa-a4f4-90855040ca73" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_TradingSymbol_618b6747-9806-49fa-a4f4-90855040ca73" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_498a8027-9d73-4865-a104-2977447c1247" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_SecurityExchangeName_498a8027-9d73-4865-a104-2977447c1247" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_4e8bfd17-ca2e-4603-8c83-f30f930f12ea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_NoTradingSymbolFlag_4e8bfd17-ca2e-4603-8c83-f30f930f12ea" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3316eef4-0766-41f6-8d6a-ca4d096607d7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityEmergingGrowthCompany_3316eef4-0766-41f6-8d6a-ca4d096607d7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4802a47d-975b-4316-ac3e-077a246d8523" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityCentralIndexKey_4802a47d-975b-4316-ac3e-077a246d8523" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ec25a63d-0b70-4330-9b2a-da35fcd5d8db" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_AmendmentFlag_ec25a63d-0b70-4330-9b2a-da35fcd5d8db" xlink:type="arc" order="22"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>pets-20250811_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:203c903d-b79e-4d7b-8b98-578e1b9f15fc,g:2c359b4f-5c7f-4790-b33d-259153bfdc3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ClassOfStockDomain_8ee35aed-1c45-4536-845c-4e1ea989b791_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0befa1d8-1c70-462d-a8ff-00740bd920a2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_f95ee01d-8b9b-4d5e-b433-11af0172df06_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2a212745-3a7f-4008-9eca-bbfb188f8321_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_36744aa1-2161-4052-b9b1-85e0675fb432_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_545529c6-06d0-43fd-bd1d-5586f4129627_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_dc8f1a2f-bc47-4e5f-8adb-bf0a54549f96_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_16419fa9-8359-45fa-8f6a-b0929f58fd88_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_32aa1fe6-e276-425c-a2a7-6738d8dbc89c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c8b57582-a691-4e73-993d-3f5b0946901b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a7e7cfb2-d767-4921-9dc0-1a1d4eab90ff_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_59aea6de-09e7-4597-bd8f-1bcb5c5c7d98_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1a433e4d-932f-4b13-ab7a-56fb8835b56d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f16e7d7c-dd5d-4c77-9e08-577976303e1b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1d3f4bec-df2e-46d6-b598-26e312930a57_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_76b71989-fdfc-4826-8673-7511caed7c48_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b6ba359e-de88-47a7-be2c-5202503109a6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_fcfe289d-b86f-4111-a2ed-a46d2df1ddf6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_033ab1f4-d5b8-4fb4-a0be-886be5188ff8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_81aff10c-23fc-43d0-ab54-5ee21ad3b7ea_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1d25ca9e-a3f9-470a-a9b7-11595a2535c3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_ba235147-5d3a-48e2-8cc7-433d6f257eb6_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_a96faedd-dda0-4500-884f-fa16a916d228_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_db6ba2ab-5f90-4abc-82f4-a17060421878_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_089483b6-5394-4daa-9bef-1a4b19dbfbb5_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d24c7dce-841f-4ed2-8d5e-2b966405ffcc_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3c6a833b-8eb1-42a6-9dc0-c3c6f8cfd4e4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a744da43-d895-48df-8112-0580ea85a01c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_36c9ace3-da89-4cc1-b801-c6f8c43549b5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>pets-20250811_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:203c903d-b79e-4d7b-8b98-578e1b9f15fc,g:2c359b4f-5c7f-4790-b33d-259153bfdc3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20250811.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_29601ee8-3332-4c79-bb11-1cfbae77bb41" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_05bf34c0-b5a0-4c2e-bf3f-c2b1bff5ecf7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_29601ee8-3332-4c79-bb11-1cfbae77bb41" xlink:to="loc_dei_DocumentInformationTable_05bf34c0-b5a0-4c2e-bf3f-c2b1bff5ecf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d69d9abe-ac7b-43be-b47d-cd829d1491c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_05bf34c0-b5a0-4c2e-bf3f-c2b1bff5ecf7" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d69d9abe-ac7b-43be-b47d-cd829d1491c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d69d9abe-ac7b-43be-b47d-cd829d1491c6" xlink:to="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9b5e4df0-17e9-497f-b8f7-997fcef2d805" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:to="loc_us-gaap_CommonStockMember_9b5e4df0-17e9-497f-b8f7-997fcef2d805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_11597c2d-af72-44e2-a307-02d27230b08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e4b938ee-36ce-4ff1-918f-847f73d5e36d" xlink:to="loc_us-gaap_PreferredStockMember_11597c2d-af72-44e2-a307-02d27230b08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_05bf34c0-b5a0-4c2e-bf3f-c2b1bff5ecf7" xlink:to="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f8f2e879-9532-4530-8ac0-a4a51d4611d2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_DocumentType_f8f2e879-9532-4530-8ac0-a4a51d4611d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8bdf7a93-c7fb-4563-88e5-96effa3ce861" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_DocumentPeriodEndDate_8bdf7a93-c7fb-4563-88e5-96effa3ce861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9501fbf9-3c4e-44ad-8add-b712e39bfbc0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityRegistrantName_9501fbf9-3c4e-44ad-8add-b712e39bfbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_262266f0-2f14-4848-b434-4550a898fd1d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_262266f0-2f14-4848-b434-4550a898fd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_97a2591e-66ff-4747-b914-62dde80d003e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityFileNumber_97a2591e-66ff-4747-b914-62dde80d003e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_144d3a38-24e2-4fba-92a8-48c11be361b1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityTaxIdentificationNumber_144d3a38-24e2-4fba-92a8-48c11be361b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f89f223a-6264-41ee-8296-5b668c7b4807" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressAddressLine1_f89f223a-6264-41ee-8296-5b668c7b4807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b812f980-8b49-41e5-982c-3ff97f5f1ef6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressCityOrTown_b812f980-8b49-41e5-982c-3ff97f5f1ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_76616c9a-4d25-435a-82b3-e5f65aedd8b2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressStateOrProvince_76616c9a-4d25-435a-82b3-e5f65aedd8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f71d0c99-8f15-4929-abb0-36ce2dbdd96f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityAddressPostalZipCode_f71d0c99-8f15-4929-abb0-36ce2dbdd96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4b9d2c69-d8b0-4ad4-9d33-b0dfb92fd766" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_CityAreaCode_4b9d2c69-d8b0-4ad4-9d33-b0dfb92fd766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_77ef755f-35dd-48ee-bba3-4f8b2ca813cf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_LocalPhoneNumber_77ef755f-35dd-48ee-bba3-4f8b2ca813cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_cac35aa4-5e98-4b40-9eef-bb551ff6f041" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_WrittenCommunications_cac35aa4-5e98-4b40-9eef-bb551ff6f041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e3ecfc5b-9d3d-4fc5-a3b2-f960fc06f8e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_SolicitingMaterial_e3ecfc5b-9d3d-4fc5-a3b2-f960fc06f8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_fce302c0-0d34-4e48-a3d2-fc558ec0c54a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_PreCommencementTenderOffer_fce302c0-0d34-4e48-a3d2-fc558ec0c54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_3e6cde84-3fb7-48ce-a7a8-58221a2b67c6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_3e6cde84-3fb7-48ce-a7a8-58221a2b67c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7e85a7b8-ab7e-413f-8abf-56954d849154" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_Security12bTitle_7e85a7b8-ab7e-413f-8abf-56954d849154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_618b6747-9806-49fa-a4f4-90855040ca73" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_TradingSymbol_618b6747-9806-49fa-a4f4-90855040ca73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_498a8027-9d73-4865-a104-2977447c1247" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_SecurityExchangeName_498a8027-9d73-4865-a104-2977447c1247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_4e8bfd17-ca2e-4603-8c83-f30f930f12ea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_NoTradingSymbolFlag_4e8bfd17-ca2e-4603-8c83-f30f930f12ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3316eef4-0766-41f6-8d6a-ca4d096607d7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityEmergingGrowthCompany_3316eef4-0766-41f6-8d6a-ca4d096607d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4802a47d-975b-4316-ac3e-077a246d8523" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_EntityCentralIndexKey_4802a47d-975b-4316-ac3e-077a246d8523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ec25a63d-0b70-4330-9b2a-da35fcd5d8db" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_25f9f1da-77fb-490a-b9e6-af1f2ff5572d" xlink:to="loc_dei_AmendmentFlag_ec25a63d-0b70-4330-9b2a-da35fcd5d8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 11,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PetMed Express, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Stock Purchase Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pets-20250811.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="pets-20250811.htm">pets-20250811.htm</File>
    <File>pets-20250811.xsd</File>
    <File>pets-20250811_def.xml</File>
    <File>pets-20250811_lab.xml</File>
    <File>pets-20250811_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "pets-20250811.htm": {
   "nsprefix": "pets",
   "nsuri": "http://www.1800petmeds.com/20250811",
   "dts": {
    "inline": {
     "local": [
      "pets-20250811.htm"
     ]
    },
    "schema": {
     "local": [
      "pets-20250811.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "pets-20250811_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20250811_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20250811_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 30,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 25
   },
   "report": {
    "R1": {
     "role": "http://www.1800petmeds.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20250811.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20250811.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "No Trading Symbol Flag",
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock [Member]",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001040130-25-000049-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001040130-25-000049-xbrl.zip
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M(-V-(+I4V*KTZ/CT2HRDQK@\/(<W";7 D[T4X.XY()T!^%&ZS$X]N[HQR;9
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M%W6_@1I_%V22ZR'ZIDSJ$=\Q_<$.K+17!SBU@>_,X)]Q.'&/_A]02P,$%
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M(18@HUT& Q2T96QD\>S2V-5-QYJPS6=;E=H*M-1J>ZO52*,190H(FAJ (82
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M$_TH*.Z8&P;#_I1&U]=R8Q"\F-[3$N/Z_.K9[0?=K^ZM^U?/_@=02P,$%
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MA^?[;T\P4)?-H/O$R\OK]*LFK_E77/X+4$L#!!0    ( )J"#%O'XG("&"T
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M-_:LC?F\=<$<R7<OQ_IQTFMP+\]ZY@=7BPR#<'MJ;'/ZY]4W&&G#Y6#_#;,
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M&*[,5?02Z^+SBEZD$>M-X[>:O5$9&:[LP!#E6B5-GR_G;:_8^QSGI6Y=:9N
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M[I8S,IQ2!,[T[(LW+,/='([3L\SNC[-V+&NJV!NV J4=E>//+<[M=_8/'^1
MM\[3L5M/Y1R1YZ>9'Y+]D$D5E,4X.VXD1DE14%T0@4ZT"'BPK.4SK 2[M;QV
MB^8E6(N"@VR(R@J[E9;4\D?R$G15%+0H"C0HM5"!#9US1S=M?JXVO]Y(N95"
MX,Y>I_NB C=Z.IT,S,'51OLY)4Z-,!P&07BRU">##T#A0Q@BZ)B ":J4LY;
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M8)W&*LVPL/Z1XY!$[T@<8&]:39Z*"ZL+[;+<3+;_V2YI9&23AI<:IQQL.]]
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MA3^8T-; 5@[@K/X(^'5< )/#&;T"!;"<,@NOT/=+(^OZ X'="JD;)G^%UBF
M;BQU\H)7)YV<R53U%1.Z7(F"'5U1ME8-W*\J+FW!]ZYD"3:G:S#$C,V:7(S4
M#[-*=%*(_JB#[B4FY!3D"%BQ@3O$BD+,V'5>()%*/O1(K5#NAAN699$A\ 64
M+Y%R=#_]E9(\0*(PCO>XY&RBF4)X92/Z@JO>YES5P4H*6-<]"72F!FU&192
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M!06,NLQTPA87<M&1GVLTMY8ZN!S6O=^JE4JC6=MRX,VG/E/9@,@4MW.S!M1
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M_Y&EDDB&.^/"-^^Z^JD,J#5#\H9K7F%RJ6L5(#'1<<7-$2C8F;+."O;6UA9
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M]!B&VU6Q]Y!CY$\1"V^IR>JG6,Y4$JMKF[J0;FHE01FO8A)0D)6CE $Z$R
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MY9?K]-#?7@*YFV7^A;:3_R0AN7?P.*3DO\^R: /_6Y:KY)?_#U!+ 0(4 Q0
M   ( )J"#%NJ;.(U)1T  .ZZ   1              "  0    !P971S+3(P
M,C4P.#$Q+FAT;5!+ 0(4 Q0    ( )J"#%OC 1N!AP(  (((   1
M      "  50=  !P971S+3(P,C4P.#$Q+GAS9%!+ 0(4 Q0    ( )J"#%OT
M>A=H@ @  &,^   5              "  0H@  !P971S+3(P,C4P.#$Q7V1E
M9BYX;6Q02P$"% ,4    " ":@@Q;C,?,H8@,   N;0  %0
M@ &]*   <&5T<RTR,#(U,#@Q,5]L86(N>&UL4$L! A0#%     @ FH(,6\C_
M^!@N"   14$  !4              ( !>#4  '!E=',M,C R-3 X,3%?<')E
M+GAM;%!+ 0(4 Q0    ( )J"#%O.S47@G H  .DB   >              "
M =D]  !P971S+3(P,C4P.#$R>&5X>#DY,7!R97-S<BYH=&U02P$"% ,4
M" ":@@Q;Q^)R A@M  "J[@  '@              @ &Q2   <&5T<RUC86UP
M;W-E>&5C<V5P87)A=&EO;F$N:'1M4$L! A0#%     @ FH(,6T$Y'?/)*P
M3^   !X              ( !!78  '!E=',M9&5L:6%E>&5C<V5P87)A=&EO
=;F%G+FAT;5!+!08     "  ( "L"   *H@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>pets-20250811_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pets-20250811.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2025-08-11</startDate>
            <endDate>2025-08-11</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-11</startDate>
            <endDate>2025-08-11</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-11</startDate>
            <endDate>2025-08-11</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0001040130</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-08-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">PetMed Express, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-28827</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">526-4444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-17">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-18">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-20">Preferred Stock Purchase Rights</dei:Security12bTitle>
    <dei:NoTradingSymbolFlag contextRef="c-3" id="f-21">true</dei:NoTradingSymbolFlag>
    <dei:SecurityExchangeName contextRef="c-3" id="f-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
